Related references
Note: Only part of the references are listed.Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Matthias Augustin et al.
ACTA DERMATO-VENEREOLOGICA (2010)
Epidemiology and comorbidity of psoriasis in children
M. Augustin et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
P. ETTEHADI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
S2k-Guideline on Treatment of Acne
Alexander Nast et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2010)
The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Efficacy and Safety of Combination Acitretin and Pioglitazone Therapy in Patients With Moderate to Severe Chronic Plaque-Type Psoriasis
Rajan Mittal et al.
ARCHIVES OF DERMATOLOGY (2009)
British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis
S. Tabolli et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2009)
A Comparative Study on the Efficacy of Treatment with 585 nm Pulsed Dye Laser and Ultraviolet B-TL01 in Plaque Type Psoriasis
Jaap de Leeuw et al.
DERMATOLOGIC SURGERY (2009)
Focused UV-B narrowband microphototherapy (Biopsorin®). A new treatment for plaque psoriasis
Torello Lotti et al.
DERMATOLOGIC THERAPY (2009)
A MULTICENTER OPEN-LABEL EXPERIENCE ON THE RESPONSE OF PSORIASIS TO ADALIMUMAB AND EFFECT OF DOSE ESCALATION IN NON-RESPONDERS: THE APHRODITE PROJECT
G. A. Vena et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
ANGIOGENESIS IN PSORIATIC SKIN AND ITS MODIFICATIONS AFTER ADMINISTRATION OF ETANERCEPT: VIDEOCAPILLAROSCOPIC, HISTOLOGICAL AND IMMUNOHISTOCHEMICAL EVALUATION
A. Campanati et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany
Matthias Augustin et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis - A retrospective study (FUTURE)
Kristian Reich et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial
M. Caproni et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
Alice Gottlieb et al.
LANCET (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Microcirculatory modifications of psoriatic lesions during topical therapy
Paolo Rosina et al.
SKIN RESEARCH AND TECHNOLOGY (2009)
Outcome of short-term Dead Sea climatotherapy for psoriasis
Arnon D. Cohen et al.
ACTA DERMATO-VENEREOLOGICA (2008)
The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy
Claus Zachariae et al.
ACTA DERMATO-VENEREOLOGICA (2008)
The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis
Tsutomu Ohtsuka
ARCHIVES OF DERMATOLOGICAL RESEARCH (2008)
Review and expert opinion on prevention and treatment of infliximab-related infusion reactions
L. L. A. Lecluse et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis:: effect of immune-targeted antipsoriatic therapies
R. G. van Lingen et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Evaluation of the efficacy and safety of infliximab on psoriatic nails: an unblinded, nonrandomized, open-label study
D. Rigopoulos et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Comparison of the efficacy of psoralen ultraviolet A with narrowband ultraviolet B phototherapy for the treatment of chronic plaque psoriasis in patients with skin types IV and V
J. Kaur et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
Economic considerations in psoriasis management
Marc Alexander Radtke et al.
CLINICS IN DERMATOLOGY (2008)
Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis
M. R. Bongiorno et al.
Dermatologic Therapy (2008)
Disease severity, quality of life and health care in plaque-type psoriasis: A multicenter cross-sectional study in Germany
M. Augustin et al.
DERMATOLOGY (2008)
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: A pilot study
Rosanne G. van Lingen et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2008)
Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination
Alexander Nast et al.
JOURNAL OF EVALUATION IN CLINICAL PRACTICE (2008)
Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period
Andrew A. Nelson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year
Phoebe Rich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry
A. Nast et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
Craig L. Leonardi et al.
LANCET (2008)
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
Kim A. Papp et al.
LANCET (2008)
The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis
Jaroslav Chladek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J. -H. Saurat et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
D. Revicki et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway
Kevin M. Elias et al.
BLOOD (2008)
The risk of mortality in patients with psoriasis - Results from a population-based study
Joel M. Gelfand et al.
ARCHIVES OF DERMATOLOGY (2007)
Comparison of cutaneous tolerance and efficacy of calcitriol 3 μg g-1 ointment and tacrolimus 0.3 mg g-1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas:: a double-blind, randomized controlled trial
Y. H. Liao et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis
Jenny Augustsson et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea
Marco Harari et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis
Francesca Capon et al.
HUMAN GENETICS (2007)
A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis
T. Brockow et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe Psoriasis
Thomas Brockow et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2007)
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
Marina Papoutsaki et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
Efficacy and safety of preprandial versus postprandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris
Hideo Hashizume et al.
JOURNAL OF DERMATOLOGY (2007)
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study
P. Gisondi et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Re-induction as a possible alternative modality of dose escalation of infliximab: A prospective evaluation in a small series of psoriatic patients
N. Cassano et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2007)
TNF polymorphisms in psoriasis -: Association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele
Kristian Reich et al.
ARTHRITIS AND RHEUMATISM (2007)
German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
A. Nast et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis - A randomized controlled trial
Ralf Schiener et al.
ARCHIVES OF DERMATOLOGY (2007)
IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases
Robert Sabat et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris
Masatoshi Abe et al.
JOURNAL OF DERMATOLOGY (2007)
A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis
Angela Moore et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 μg/g ointment vs. calcipotriol 50 μg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis
X. Zhu et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy
C. Andrys et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Psoriasis: a possible risk factor for development of coronary artery calcification
R. J. Ludwig et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A classification of psoriasis vulgaris according to phenotype
C. E. M. Griffiths et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes
Michele Cargill et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice
Maartje A. M. Berends et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
Cost-effectiveness model of topical treatment of mild to moderate psoriasis vulgaris in Germany
M. Augustin et al.
DERMATOLOGY (2007)
Clinical and immunohistochemical assessment of the effect of cyclosporin in keratinocytes and dermal dendrocytes in psoriasis
Eduardo Lago et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2007)
A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation
J. E. M. Korver et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Soluble tumour necrosis factor-alpha receptor type 1 as a biomarker of response to phototherapy in patients with psoriasis
Agnieszka B. Serwin et al.
BIOMARKERS (2007)
A comparison of two cyclosporine dosage regimens for the treatment of severe psoriasis
Hyun Sun Yoon et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet (R)) versus calcipotriol (Daivonex (R)) in the treatment of psoriasis vulgaris: A randomized, multicentre, clinical trial
Rosita Saraceno et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2007)
Cutaneous vascular alterations in psoriatic patients treated with cyclosporine
Giuseppe Stinco et al.
ACTA DERMATO-VENEREOLOGICA (2007)
Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis
Gemma Martin Ezquerra et al.
ACTA DERMATO-VENEREOLOGICA (2007)
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients
Ulrich Mrowietz et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)
Risk of myocardial infarction in patients with psoriasis
Joel M. Gelfand et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis
Rujirat Vongthongsri et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting
P. C. M. van de Kerkhof et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: Short- and long-term outcomes
John Koo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Clinical response to alimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
Kenneth B. Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Selenium supplementation, soluble tumor necrosis factor-α receptor type 1, and C-reactive protein during psoriasis therapy with narrowband ultraviolet B
Agnieszka Beata Serwin et al.
NUTRITION (2006)
Randomized double-blind trial of the treatment of chronic plaque psoriasis - Efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy
Sami S. Yones et al.
ARCHIVES OF DERMATOLOGY (2006)
Infliximab for severe, treatment-resistant psoriasis: a prospective, open-label study
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial
A. Salim et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: A randomized, placebo-controlled study
Pravit Asawanonda et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Adherence to treatment in patients with psoriasis
HL Richards et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis
A Pacifico et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
Daily versus intermittent application of high-concentration tacalcitol ointment in combination with low-dose cyclosporin for psoriasis vulgaris
Masatoshi Abe et al.
JOURNAL OF DERMATOLOGY (2006)
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial
S Tyring et al.
LANCET (2006)
A randomized, double-blind, vehicle-controlled, bilateral comparison trial of bexarotene gel 1% versus vehicle gel in combination with narrowband UVB phototherapy for moderate to severe psoriasis vulgaris
MA Magliocco et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Use of calcipotriene cream (Dovonex (R) cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex (R)) - A randomized, parallel-group clinical trial
Stephen White et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2006)
Treatment of psoriasis vulgaris with the two-compound product calcipotriol/betamethasone dipropionate followed by different formulations of calcipotriol
Nicoletta Cassano et al.
CLINICAL DRUG INVESTIGATION (2006)
Short contact therapy with tazarotene in psoriasis vulgaris
S Veraldi et al.
DERMATOLOGY (2006)
Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris
Simone Maria Goldinger et al.
DERMATOLOGY (2006)
Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis
SM Taibjee et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
Non-invasive evaluation of tacalcitol plus PUVA versus tacalcitol plus UVB-NB in the treatment of psoriasis: Right left intra-individual - Pre/post comparison design
V Brazzelli et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial
C Antoni et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
KA Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis
N Lowe et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2005)
Psychosocial consequences of psoriasis - an empirical study on the burden of skin disease in 3753 patients
G Schmid-Ott et al.
HAUTARZT (2005)
Remission and time of resolution of nail psoriasis during infliximab therapy
L Bianchi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Dimethylfumarate for psoriasis: more than a dietary curiosity
U Mrowietz et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment
CL Carroll et al.
ARCHIVES OF DERMATOLOGY (2005)
Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis
M Grundmann-Kollmann et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Objective assessment of compliance with psoriasis treatment
SS Zaghloul et al.
ARCHIVES OF DERMATOLOGY (2004)
Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities
P Balasubramaniam et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction
RS Stern et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2004)
Randomized half-side comparison of narrowband UVB and trimethylpsoralen bath plus UVA treatments for psoriasis
E Snellman et al.
ACTA DERMATO-VENEREOLOGICA (2004)
Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
AB Gottlieb et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Association of cyclosporine and 311 nM UVB in the treatment of moderate to severe forms of psoriasis: A new strategic approach
C Franchi et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2004)
Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis
E Schuller et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Etanercept treatment of psoriatic arthritis - Safety, efficacy, and effect on disease progression
PJ Mease et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: A randomised, double-blind trial
JP Ortonne et al.
DERMATOLOGY (2004)
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
C Gribetz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Psoriasis of the glans penis in a child successfully treated with ElidelR (pimecrolimus) cream
B Amichai
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2004)
Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris
K Kragballe et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
A randomized trial of etanercept as monotherapy for psoriasis
AB Gottlieb et al.
ARCHIVES OF DERMATOLOGY (2003)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids
ES Kalthoff et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
VMR Heydendael et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion
U Mrowietz et al.
ACTA DERMATO-VENEREOLOGICA (2003)
Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
JJ Hoefnagel et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis
TS Housman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
GD Weinstein et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions
AB Gottlieb et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2003)
Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas
AK Freeman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Efficacy of acitretin and commercial tanning bed therapy for psoriasis
CS Carlin et al.
ARCHIVES OF DERMATOLOGY (2003)
Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines
NHR Litjens et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study
CF Paul et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes
JE Gudjonsson et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Multiple cutaneous squamous carcinoma in a psoriatic associated with ciclosporin, alcohol abuse and ultraviolet radiation exposure which were suppressed by acitretin
KL Agnew et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2003)
Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis
KA Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Dimethylfumarate is a potent inducer of apoptosis in human T cells
F Treumer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial
SR McBride et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Medium-dose 308-nm excimer laser for the treatment of psoriasis
M Trehan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
The suitability of quality-of-life questionnaires for psoriasis research - A systematic literature review
J de Korte et al.
ARCHIVES OF DERMATOLOGY (2002)
Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial
L Guenther et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A novel liposomal formulation of dithranol for psoriasis: Preliminary results
R Agarwal et al.
JOURNAL OF DERMATOLOGY (2002)
Calcipotriol plus short-contact dithranol: A novel topical combination therapy for chronic plaque psoriasis
A Monastirli et al.
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY (2002)
Treatment of psoriasis with the chimeric monoclonal antibody against tumor necrosis factor α, infliximab
RE Schopf et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study
SR Feldman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis
M Lebwohl et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)
Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid
OQJ Swinkels et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A new calcipotriol/beta methasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris
WS Douglas et al.
ACTA DERMATO-VENEREOLOGICA (2002)
Body-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis - A randomised study
D Thaci et al.
DERMATOLOGY (2002)
Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis
PCM Van de Kerkhof et al.
DERMATOLOGY (2002)
A new calcipotriol/betamethasone dipropionate formulation (Daivobet (TM)) is an effective once-daily treatment for psoriasis vulgaris
R Kaufmann et al.
DERMATOLOGY (2002)
Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris
H Gollnick et al.
DERMATOLOGY (2002)
Topical preparations for the treatment of psoriasis: a systematic review
J Mason et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy
DG Fortune et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis
L Green et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2002)
1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells
A Boonstra et al.
JOURNAL OF IMMUNOLOGY (2001)
Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study
I Marcil et al.
LANCET (2001)
Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial
S Reitamo et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Combined mycophenolate mofetil and cyclosporin therapy for severe recalcitrant psoriasis
M Ameen et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2001)
A comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths
WP Arnold et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Betamethasone valerate foam for treatment of nonscalp psoriasis
LF Stein et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2001)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study
VCY Ho et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Calcitriol 3 μg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis:: results of a comparative study
J Ring et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis
JYM Koo et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2001)
Inhibition of dendritic cell differentiation by fumaric acid esters
KJ Zhu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis
G Schmid-Ott et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Tazarotene plus UVB phototherapy in the treatment of psoriasis
JYM Koo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2000)
Psoralen-ultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with Fitzpatrick skin type IV
K Khurshid et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2000)
A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis
LC Guenther et al.
CLINICAL THERAPEUTICS (2000)
Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: A safe, effective and UVB-sparing antipsoriatric combination treatment
CA Ramsay et al.
DERMATOLOGY (2000)
Dithranol in a cream preparation: Disperse or dissolve?
M Prins et al.
SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY (2000)
The efficacy, safety and tolerance of calcitriol 3 mu g/g ointment in the treatment of plaque psoriasis: A comparison with short-contact dithranol
PE Hutchinson et al.
DERMATOLOGY (2000)
Share Paper
